Sign In
Buy CLSD
$0.410
+0 (+0%)
At Close: Mar 13, 2026
CLSD Stock: The Big News Lifting Clearside Biomedical Today
02:18pm, Tuesday, 15'th Jun 2021
Today, investors in CLSD stock are seeing gains of nearly 50% as the company announced positive results from one of its clinical trials. The post CLSD Stock: The Big News Lifting Clearside Biomedical
Where Will The Clearside Biomedical Stock Rally End?
10:52am, Tuesday, 15'th Jun 2021
Shares of Clearside Biomedical, Inc. (NASDAQ: CLSD) are skyrocketing Tuesday morning after the company announced positive safety results for a treatment for eye diseases. If Clearside makes it to the
CLSD Stock Price Increases Over 35% Pre-Market: Why It Happened
09:11am, Tuesday, 15'th Jun 2021
The stock price of Clearside Biomedical Inc (NASDAQ: CLSD) increased by over 35% pre-market. This is why it happened.
- CLS-AX 0.03 mg dose delivered via suprachoroidal injection was well-tolerated with no treatment related adverse events -
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in June 2021
07:05am, Wednesday, 09'th Jun 2021
ALPHARETTA, Ga., June 09, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vi
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q1 2021 Results - Earnings Call Transcript
10:34pm, Monday, 17'th May 2021
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q1 2021 Results - Earnings Call Transcript
Recap: Clearside Biomedical Q1 Earnings
04:36pm, Monday, 17'th May 2021
Shares of Clearside Biomedical (NASDAQ:CLSD) rose after the company reported Q1 results. Quarterly Results Earnings per share decreased 85.71% over the past year to ($0.13), which missed the estimate
Clearside Biomedical Announces First Quarter 2021 Financial Results and Provides Corporate Update
04:05pm, Monday, 17'th May 2021
- Recent New Drug Application Resubmission for XIPERE TM
ScPharmaceuticals: The Third Time's A Charm
09:11am, Wednesday, 12'th May 2021
ScPharmaceuticals: The Third Time's A Charm
Analysts Estimate Clearside Biomedical, Inc. (CLSD) to Report a Decline in Earnings: What to Look Out for
03:47pm, Monday, 10'th May 2021
Clearside Biomedical, Inc. (CLSD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Presentations support proprietary suprachoroidal space delivery platform and programs Presentations support proprietary suprachoroidal space delivery platform and programs
Clearside Biomedical to Report First Quarter 2021 Financial Results and Provide Corporate Update on Monday, May 17, 2021
07:05am, Tuesday, 04'th May 2021
ALPHARETTA, Ga., May 04, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vis
ALPHARETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vi
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit
07:05am, Monday, 05'th Apr 2021
ALPHARETTA, Ga., April 05, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve v
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q4 2020 Results - Earnings Call Transcript
09:57pm, Wednesday, 10'th Mar 2021
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q4 2020 Results - Earnings Call Transcript
